NTRK fusion in metastatic castration-resistant prostate cancer treated with entrectinib: a case report
{{output}}
Background: The tropomyosin receptor kinase (TRK) inhibitors have demonstrated substantial efficacy in solid tumors harboring neurotrophic tyrosine receptor kinase (NTRK) gene fusions. Although NTRK fusions have been sporadically... ...
